HomeVXL • CVE
add
Vaxil Bio Ltd
Previous close
$0.17
Day range
$0.17 - $0.17
Year range
$0.16 - $0.33
Market cap
466.07K CAD
Avg Volume
712.00
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 37.00K | -11.90% |
Net income | 42.00K | 185.71% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 347.00K | -41.09% |
Total assets | 697.00K | -19.24% |
Total liabilities | 6.00K | -92.11% |
Total equity | 691.00K | — |
Shares outstanding | 2.74M | — |
Price to book | 0.68 | — |
Return on assets | -13.40% | — |
Return on capital | -13.86% | — |
Cash Flow
Net change in cash
(CAD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | 42.00K | 185.71% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2006
Headquarters
Website